長聖全球首例以ai進行新藥car-t篩選 獲tfda核准臨床

長聖(6712)10日宣布,該公司旗下異體CAR001(CAR-T)以AI篩選出HLA-G靶點治療實體癌之Phase I...

This is a companion discussion topic for the original entry at https://udn.com/news/story/7241/8087109